Can eye drops and special glasses stop Kids' nearsightedness from getting worse?

NCT ID NCT06523504

Recruiting now Disease control Sponsor: Ruihua Wei Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether low-dose atropine eye drops (0.02% or 0.04%) combined with special glasses (DIMS) can slow the progression of moderate to high myopia (nearsightedness) in children aged 6 to 12. About 410 children will be assigned to different treatment groups and followed for changes in eye length and prescription. The goal is to find a safe, effective way to control myopia and reduce future eye health risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: atropine eye drops (0.02% and 0.04%) and defocus incorporated multiple segments (DIMS) glasses
What this could lead to: If successful, this could offer a safe, non-surgical way to slow down worsening nearsightedness in children, reducing their risk of eye problems later in life.
What could go wrong: This is an early-phase trial (Phase 1/2) with a moderate number of participants. The treatments may not work better than existing options, and atropine can cause side effects like light sensitivity or blurry near vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Tianjin Medical University Eye Hospital
RECRUITING

Tianjin, Tianjin Municipality, 120120, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.